Australian prescription data reveals Real-World prostate cancer treatment trends
NCT ID NCT07223372
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times
Summary
This study looks at prescription records from Australian databases to understand how men with advanced prostate cancer are treated in everyday practice. Researchers will analyze data from 1,000 adult men to see which drugs are used, how long they are taken, and patient characteristics like age and location. The goal is to learn how well current treatments work outside of clinical trials, helping doctors improve care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONESENSITIVE PROSTATE CANCER (MHSPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayer
RECRUITINGPymble, New South Wales, 875, Australia
Conditions
Explore the condition pages connected to this study.